A Prospective, Multicenter Phase II Study of the Efficacy and Feasibility of 15-minute Panitumumab Infusion Plus Irinotecan for Oxaliplatin- and Irinotecan-refractory, KRAS Wild-type Metastatic Colorectal Cancer (Short Infusion of Panitumumab Trial)

2018 ◽  
Vol 17 (1) ◽  
pp. e83-e89 ◽  
Author(s):  
Kohei Akiyoshi ◽  
Tetsuya Hamaguchi ◽  
Kenichi Yoshimura ◽  
Naoki Takahashi ◽  
Yoshitaka Honma ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Wild Type ◽  
Multicenter Phase ◽  
Short Infusion

A single-arm, multicenter, phase II study of panitumumab in combination with capecitabine/oxaliplatin in first line, wild-type KRAS metastatic colorectal cancer patients.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e14563-e14563
Author(s):  
Dimitrios G. Pectasides ◽  
Vasilios Karavasilis ◽  
Vassiliki Kotoula ◽  
Epaminontas Samantas ◽  
Zoi Alexopoulou ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Wild Type ◽  
First Line ◽  
Multicenter Phase ◽  
Colorectal Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document